These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35277718)

  • 1. Can rapamycin slow down memory decline in Alzheimer's disease with seizures?
    Shetty AK
    Brain; 2022 Mar; 145(1):14-16. PubMed ID: 35277718
    [No Abstract]   [Full Text] [Related]  

  • 2. mTOR Attenuation with Rapamycin Reverses Neurovascular Uncoupling and Memory Deficits in Mice Modeling Alzheimer's Disease.
    Van Skike CE; Hussong SA; Hernandez SF; Banh AQ; DeRosa N; Galvan V
    J Neurosci; 2021 May; 41(19):4305-4320. PubMed ID: 33888602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease. Arresting memory decline.
    Robbins TW
    Nature; 1988 Nov; 336(6196):207-8. PubMed ID: 2848195
    [No Abstract]   [Full Text] [Related]  

  • 4. Memory loss in Alzheimer's disease: implications for development of therapeutics.
    Gold CA; Budson AE
    Expert Rev Neurother; 2008 Dec; 8(12):1879-91. PubMed ID: 19086882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid lowering agents are associated with a slower cognitive decline in Alzheimer's disease.
    Masse I; Bordet R; Deplanque D; Al Khedr A; Richard F; Libersa C; Pasquier F
    J Neurol Neurosurg Psychiatry; 2005 Dec; 76(12):1624-9. PubMed ID: 16291883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How longevity research can lead to therapies for Alzheimer's disease: The rapamycin story.
    Richardson A; Galvan V; Lin AL; Oddo S
    Exp Gerontol; 2015 Aug; 68():51-8. PubMed ID: 25481271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epilepsy and Alzheimer's Disease: Current Concepts and Treatment Perspective on Two Closely Related Pathologies.
    Leo A; Tallarico M; Sciaccaluga M; Citraro R; Costa C
    Curr Neuropharmacol; 2022; 20(11):2029-2033. PubMed ID: 35524669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Not having verbal repetitiveness might increase confidence that cognitive concerns in ageing are not due to Alzheimer's disease.
    Ong KT; Woodward M
    Aust N Z J Psychiatry; 2017 Jul; 51(7):744-745. PubMed ID: 28633572
    [No Abstract]   [Full Text] [Related]  

  • 9. Chronic treatment with DCPCX, an adenosine A(1) antagonist, worsens long-term memory.
    Vollert C; Forkuo GS; Bond RA; Eriksen JL
    Neurosci Lett; 2013 Aug; 548():296-300. PubMed ID: 23748072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin treatment alters memory function in a mouse model of Alzheimer's disease.
    DiTacchio KA; Heinemann SF; Dziewczapolski G
    J Alzheimers Dis; 2015; 44(1):43-8. PubMed ID: 25190626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can testosterone replacement decrease the memory problem of old age?
    Lim D; Flicker L; Dharamarajan A; Martins RN
    Med Hypotheses; 2003 Jun; 60(6):893-6. PubMed ID: 12699720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternatives in the treatment of memory loss in patients with Alzheimer's disease.
    Volger BW
    Clin Pharm; 1991 Jun; 10(6):447-56. PubMed ID: 2065522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive subdomain responses to galantamine in Alzheimer's disease.
    Song J; Ahn IS; Kang HS; Myung W; Lee Y; Woo SY; Ku HM; Hwang TY; Carroll BJ; Kim DK
    J Nerv Ment Dis; 2014 Mar; 202(3):253-9. PubMed ID: 24566512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of Memory Impairment in Early Diagnosis of Alzheimer's Disease.
    Vyhnálek M; Marková H; Laczó J; De Beni R; Di Nuovo S
    Curr Alzheimer Res; 2019; 16(11):975-985. PubMed ID: 31724515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Working memory binding and episodic memory formation in aging, mild cognitive impairment, and Alzheimer's dementia.
    van Geldorp B; Heringa SM; van den Berg E; Olde Rikkert MG; Biessels GJ; Kessels RP
    J Clin Exp Neuropsychol; 2015; 37(5):538-48. PubMed ID: 26011711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Episodic memory in Alzheimer's disease: decline in recollection and familiarity?].
    Simon J; Bastin C
    Med Sci (Paris); 2014; 30(8-9):784-9. PubMed ID: 25174756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A critical review of available tools for evaluating memory enhancers in Alzheimer's disease].
    Poitrenaud J; Kalafat M; Israel L; Guez D
    Rev Med Interne; 1997; 18(1):59-71. PubMed ID: 9092020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FASTKD2 and human memory: functional pathways and prospects for novel therapeutic target development for Alzheimer's disease and age-associated memory decline.
    Ramanan VK; Saykin AJ
    Pharmacogenomics; 2015; 16(5):429-32. PubMed ID: 25916514
    [No Abstract]   [Full Text] [Related]  

  • 19. [Memory and language disorders in Alzheimer's dementia].
    Eustache F
    Rev Neurol (Paris); 1992; 148(3):184-92. PubMed ID: 1604132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in pharmacotherapy for decline of memory and cognition in patients with Alzheimer's disease.
    Kumar V; Goldstein MZ; Doraiswamy PM
    Psychiatr Serv; 1996 Mar; 47(3):249-53. PubMed ID: 8820547
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.